Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk

Parazzini, 1991, The epidemiology of endometrial cancer, Gynecol Oncol, 41, 1, 10.1016/0090-8258(91)90246-2 Horn-Ross, 2003, Phytoestrogen intake and endometrial cancer risk, JNCI, 95, 1158, 10.1093/jnci/djg015 McPherson, 1996, Reproductive factors and risk of endometrial cancer. The Iowa women's health study, Am J Epidemiol, 143, 1195, 10.1093/oxfordjournals.aje.a008707 1996, Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial, JAMA, 275, 370, 10.1001/jama.275.5.370 Stanford, 1993, Oral contraceptives and endometrial cancer: do other risk factors modify the association?, Int J Cancer, 54, 243, 10.1002/ijc.2910540214 Randall, 1997, Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40, Obstet Gynecol, 90, 434, 10.1016/S0029-7844(97)00297-4 Rosenblatt, 1991, Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma: the WHO collaborative study of neoplasia and steroid contraceptives, Int J Cancer, 49, 870, 10.1002/ijc.2910490612 Schildkraut, 2002, Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer sik, J Natl Cancer Inst, 94, 32, 10.1093/jnci/94.1.32 Rodriguez, 1998, Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?, J Soc Gynecol Invest, 5, 271, 10.1016/S1071-5576(98)00017-3 Rodriguez, 2001, Regulation of invasion of epithelial ovarian cancer by TGF-Beta, Gynecol Oncol, 80, 245, 10.1006/gyno.2000.6042 Anonymous, 1987, Combination oral contraceptive use and the risk of endometrial cancer. The cancer and steroid hormone study of the centers for disease control and the national institute of child health and human development, JAMA, 257, 796, 10.1001/jama.257.6.796 Piper, 1987, Oral contraceptive in the United States: trends in content and potency, Int J Epidemiol, 16, 215, 10.1093/ije/16.2.215 Anonymous, 1988, Endometrial cancer and combined oral contraceptives. The who collaborative study of neoplasia and steroid contraceptives, Int J Epidemiol, 17, 263, 10.1093/ije/17.2.263 Voigt, 1994, Recency, duration and progestin content of oral contraceptives in relation to the incidence of endometrial cancer, Cancer Causes Control, 5, 227, 10.1007/BF01830241 Reis, 2002, Regulation of human endometrial transforming growth factor beta1 and beta3 isoforms through menstrual cycle and medroxyprogesterone acetate treatment, Histol Histopathol, 17, 739 Bianchini, 2002, Overweight, obesity and cancer risk, Lancet Oncol, 3, 565, 10.1016/S1470-2045(02)00849-5 Goodman, 1997, Diet, body size, physical activity, and the risk of endometrial cancer, Cancer Res, 57, 5077 Bergsrtom, 2001, Overweight as an avoidable cause of cancer in Europe, Int J Cancer, 91, 421, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T American Obesity Association: http//www.obesity.org/subs/fastfacts/obesity_US.shtml. National Health and Nutrition Examination Survey (NHANES) by the Centers for Disease Control. Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, NEJM, 348, 1625, 10.1056/NEJMoa021423